Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Myriad Genetics (MYGN) over the last 17 years, with Q3 2025 value amounting to $12.6 million.

  • Myriad Genetics' Depreciation & Amortization (CF) fell 1923.08% to $12.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.9 million, marking a year-over-year decrease of 910.57%. This contributed to the annual value of $61.2 million for FY2024, which is 113.09% down from last year.
  • Latest data reveals that Myriad Genetics reported Depreciation & Amortization (CF) of $12.6 million as of Q3 2025, which was down 1923.08% from $14.1 million recorded in Q2 2025.
  • In the past 5 years, Myriad Genetics' Depreciation & Amortization (CF) ranged from a high of $19.4 million in Q1 2023 and a low of $12.6 million during Q3 2025
  • In the last 5 years, Myriad Genetics' Depreciation & Amortization (CF) had a median value of $14.2 million in 2021 and averaged $14.7 million.
  • As far as peak fluctuations go, Myriad Genetics' Depreciation & Amortization (CF) tumbled by 6284.92% in 2021, and later skyrocketed by 4923.08% in 2023.
  • Myriad Genetics' Depreciation & Amortization (CF) (Quarter) stood at $13.3 million in 2021, then increased by 3.01% to $13.7 million in 2022, then increased by 10.22% to $15.1 million in 2023, then dropped by 1.99% to $14.8 million in 2024, then dropped by 14.86% to $12.6 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $12.6 million for Q3 2025, versus $14.1 million for Q2 2025 and $14.4 million for Q1 2025.